West Pharmaceutical Services (NYSE:WST) Issues Q2 2026 Earnings Guidance
West Pharmaceutical Services (NYSE:WST – Get Free Report) issued an update on its second quarter 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 2.050-2.120 for the period, compared to the consensus EPS estimate of 2.000. The company issued revenue guidance of $830.0 million-$850.0 million, compared to the consensus revenue estimate of […]
24 Apr 14:14 · The Markets Daily